$135 Million is the total value of Data Collective IV GP, LLC's 6 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Evolv Technologies Holdings, Inc. | $63,607,684 | +92.3% | 10,601,281 | 0.0% | 47.09% | +33.6% | ||
| RXRX | Recursion Pharmaceuticals, Inc.cl a | $44,380,166 | +12.0% | 5,941,120 | 0.0% | 32.86% | -22.2% | |
| Rocket Lab USA, Inc. | $17,576,100 | +48.5% | 2,929,350 | 0.0% | 13.01% | +3.2% | ||
| Embark Technology, Inc. | $9,111,982 | +1.8% | 3,186,007 | 0.0% | 6.75% | -29.3% | ||
| Mind Medicine (MindMed) Inc. | $358,250 | +12.6% | 100,350 | 0.0% | 0.26% | -21.8% | ||
| Roivant Sciences Ltd. | $39,060 | +36.6% | 3,875 | 0.0% | 0.03% | -3.3% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Recursion Pharmaceuticals, Inc. | 8 | Q3 2023 | 50.0% |
| Evolv Technologies Holdings, Inc. | 8 | Q3 2023 | 47.1% |
| Rocket Lab USA, Inc. | 5 | Q4 2022 | 11.6% |
| Mind Medicine (MindMed) Inc. | 5 | Q4 2022 | 4.1% |
| Embark Trucks, Inc. | 4 | Q2 2023 | 18.7% |
| Roivant Sciences Ltd. | 4 | Q3 2023 | 0.2% |
| Embark Trucks, Inc. | 3 | Q2 2022 | 79.7% |
| Rocket Lab USA, Inc. | 3 | Q3 2023 | 13.0% |
| Mind Medicine (MindMed) Inc. | 3 | Q3 2023 | 0.3% |
View Data Collective IV GP, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR/A | 2022-11-14 |
| 4 | 2022-09-01 |
View Data Collective IV GP, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.